American International Group, Inc. Nymox Pharmaceutical Corp Transaction History

American International Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.46 - $2.48 $35,987 - $61,129	-24,649 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$2.22 - $3.39 $144 - $220	65 Added 0.26%	24,649 $55,000
Q4 2020 Feb 12, 2021	SELL	$1.84 - $2.83 $761 - $1,171	-414 Reduced 1.66%	24,584 $61,000
Q3 2020 Nov 04, 2020	BUY	$2.3 - $3.66 $2,046 - $3,257	890 Added 3.69%	24,998 $62,000
Q2 2020 Aug 12, 2020	BUY	$2.1 - $4.6 $50,626 - $110,896	24,108 New	24,108 $86,000
Q2 2019 Aug 13, 2019	SELL	$1.33 - $2.12 $27,463 - $43,775	-20,649 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$1.57 - $2.71 $1,048 - $1,810	-668 Reduced 3.13%	20,649 $41,000
Q4 2018 Feb 13, 2019	SELL	$1.31 - $2.53 $214 - $414	-164 Reduced 0.76%	21,317 $28,000
Q3 2018 Nov 09, 2018	BUY	$2.46 - $3.7 $952 - $1,431	387 Added 1.83%	21,481 $53,000
Q2 2018 Aug 08, 2018	BUY	$3.12 - $4.33 $2,829 - $3,927	907 Added 4.49%	21,094 $71,000
Q1 2018 May 07, 2018	SELL	$3.09 - $4.43 $3,355 - $4,810	-1,086 Reduced 5.11%	20,187 $85,000
Q4 2017 Feb 09, 2018	BUY	$3.29 - $4.06 $7,103 - $8,765	2,159 Added 11.3%	21,273 $70,000
Q3 2017 Nov 09, 2017	BUY	$3.36 - $4.02 $64,223 - $76,838	19,114	19,114 $73,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.